Correlation Between Bristol Myers and Grayscale Stellar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Grayscale Stellar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Grayscale Stellar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Grayscale Stellar Lumens, you can compare the effects of market volatilities on Bristol Myers and Grayscale Stellar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Grayscale Stellar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Grayscale Stellar.

Diversification Opportunities for Bristol Myers and Grayscale Stellar

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bristol and Grayscale is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Grayscale Stellar Lumens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grayscale Stellar Lumens and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Grayscale Stellar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grayscale Stellar Lumens has no effect on the direction of Bristol Myers i.e., Bristol Myers and Grayscale Stellar go up and down completely randomly.

Pair Corralation between Bristol Myers and Grayscale Stellar

Assuming the 90 days horizon Bristol Myers is expected to generate 3.36 times less return on investment than Grayscale Stellar. But when comparing it to its historical volatility, Bristol Myers Squibb is 2.64 times less risky than Grayscale Stellar. It trades about 0.13 of its potential returns per unit of risk. Grayscale Stellar Lumens is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  2,320  in Grayscale Stellar Lumens on September 19, 2024 and sell it today you would earn a total of  2,280  from holding Grayscale Stellar Lumens or generate 98.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy96.88%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Grayscale Stellar Lumens

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.
Grayscale Stellar Lumens 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Grayscale Stellar Lumens are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Grayscale Stellar displayed solid returns over the last few months and may actually be approaching a breakup point.

Bristol Myers and Grayscale Stellar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Grayscale Stellar

The main advantage of trading using opposite Bristol Myers and Grayscale Stellar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Grayscale Stellar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grayscale Stellar will offset losses from the drop in Grayscale Stellar's long position.
The idea behind Bristol Myers Squibb and Grayscale Stellar Lumens pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance